1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015

End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015" provides data on the End-Stage Kidney Disease (end-stage renal disease or ESRD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on End-Stage Kidney Disease (end-stage renal disease or ESRD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating End-Stage Kidney Disease (end-stage renal disease or ESRD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

End-Stage Kidney Disease (end-stage renal disease or ESRD) Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 7
End-Stage Kidney Disease (end-stage renal disease or ESRD) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of End-Stage Kidney Disease (end-stage renal disease or ESRD) 26
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on End-Stage Kidney Disease (end-stage renal disease or ESRD) 35
Nov 13, 2014: Sotatercept Data from the Phase 2a Clinical Trial in Hemodialysis Patients Presented at the American Society of Nephrology Kidney Week 2014 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Sanofi 42
Clinical Trial Overview of Sanofi 42
Shire Plc 43
Clinical Trial Overview of Shire Plc 43
Merck and Co., Inc. 44
Clinical Trial Overview of Merck and Co., Inc. 44
Baxter International Inc. 45
Clinical Trial Overview of Baxter International Inc. 45
AbbVie Inc. 46
Clinical Trial Overview of AbbVie Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
Vanderbilt University 47
Clinical Trial Overview of Vanderbilt University 47
Isfahan University of Medical Sciences 48
Clinical Trial Overview of Isfahan University of Medical Sciences 48
The National Institute of Diabetes and Digestive and Kidney Diseases 49
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 49
Massachusetts General Hospital 50
Clinical Trial Overview of Massachusetts General Hospital 50
Ege University 51
Clinical Trial Overview of Ege University 51
Shiraz University of Medical Sciences 52
Clinical Trial Overview of Shiraz University of Medical Sciences 52
The National Institute of Allergy and Infectious Diseases 53
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53
The University of Hong Kong 54
Clinical Trial Overview of The University of Hong Kong 54
University of Michigan 55
Clinical Trial Overview of University of Michigan 55
University of Washington 56
Clinical Trial Overview of University of Washington 56
Five Key Clinical Profiles 57
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106

List of Tables

End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2015* 8
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 13
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 14
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15
Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 19
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2015* 22
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Suspended Clinical Trials, 2015* 26
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Terminated Clinical Trials, 2015* 28
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 36
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 38
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 39
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 40
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 41
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 42
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 43
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 44
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 45
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 46
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 47
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 48
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 49
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 50
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ege University, 2015* 51
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 52
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 53
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2015* 54
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 55
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 56

List of Figures

End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2015* 8
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 14
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15
Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 16
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of End-Stage Kidney Disease (end-stage renal disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 19
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
End-Stage Kidney Disease (end-stage renal disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

Polycystic kidney disease (PKD)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Polycystic kidney disease (PKD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023

Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Polycystic kidney disease (PKD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Polycystic kidney disease (PKD) in seven major markets (US, France, ...

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by Global Data

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.